Breadcrumb

What's New at the RI-MUHC ?

Promising development in the fight with cancer using artificial intelligence

New privacy-preserving approach uses hospital based medical notes to refine predictions and prognosis in cancer...

New G protein inhibitor identified, with potential for cancer therapies

RI-MUHC team publishes study in Nature Communications describing a novel molecule that inhibits growth of cancer cells

RI-MUHC researchers contribute to global study of babies born with birth defects

A new study published in The Lancet finds that survival for babies born with a birth defect – otherwise known...

New Quebec study evaluates long-term complications of COVID-19

RI-MUHC researcher Thao Huynh has been awarded a grant from Pfizer to conduct the IMPACT QUEBEC COVID-19 Long Haul Study

RI-MUHC team identifies potential diagnostic biomarker for pancreatic cancer

Study demonstrates that regenerative protein 3A/3B promotes a newly recognized precursor of pancreatic...

Fever is now more often a sign of serious bacterial infection

RI-MUHC researchers advocate for extra vigilance with feverish infants as new study shows startling numbers of serious bacterial infections during...

Does the COVID-19 vaccine work for people living with HIV?

RI-MUHC scientist Dr. Cecilia Costiniuk is co-principal investigator in a new national study that hopes to answer critical questions around the...

How does the hunger-suppressing hormone leptin cross the blood-brain barrier?

Specialized cells called pericytes play a key role, reveals new work from researchers at the RI-MUHC

Recurrent miscarriage: what if the cause is genetic?

Next-generation gene sequencing may provide answers for some women dealing with recurrent pregnancy loss and prevent further miscarriages

New study paves the way to novel treatment for Triple Negative Breast Cancer

A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development...

Learn more about the RI-MUHC